Comments

Calidi Biotherapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Calidi Biotherapeutics (CLDI) operate in?

Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

CLDIAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.8775

0.033.17%

Pre-Market: 8:31 AM EDT

Calidi Biotherapeutics (CLDI) Forecast

News Earnings Calidi Biotherapeutics (CLDI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Calidi Biotherapeutics Stock Price, Quotes and Forecasts | AMEX:CLDI | Benzinga

Explore Calidi Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLDI.

Open	-
Close	-
Volume / Avg.	48.99K / 1.59M
Day Range	- - -
52 Wk Range	0.58 - 8.30
Market Cap	$22.74M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	44
Short Interest	4.73%
Days to Cover	1

Recent News

Why Calidi Biotherapeutics (CLDI) Stock Is Down 30%

Calidi Biotherapeutics shares are trading lower by 32% during Friday's session. The company priced its public offering of 5 million shares of common stock at $0.85 per share.

Henry Khederian

Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	48.99K / 1.59M
Day Range	- - -
52 Wk Range	0.58 - 8.30
Market Cap	$22.74M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	44
Short Interest	4.73%
Days to Cover	1

About Calidi Biotherapeutics Inc

Sector

Health Care

Industry

Biotechnology

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Calidi Biotherapeutics (CLDI) stock?

You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.

View our list of the best stock brokerages

Who are Calidi Biotherapeutics (CLDI) competitors?

Other companies in Calidi Biotherapeutics’s space includes: Curis (NASDAQ:CRIS), CARISMA Therapeutics (NASDAQ:CARM), Nanoviricides (AMEX:NNVC), Palatin Techs (AMEX:PTN) and GlycoMimetics (NASDAQ:GLYC).

What is the forecast, or price target, for Calidi Biotherapeutics (CLDI) stock?

Calidi Biotherapeutics has a consensus price target of $1.67.

What is the current price for Calidi Biotherapeutics (CLDI)?

The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $0.8775 last updated March 10, 2025 at 8:31 AM EDT.

Does Calidi Biotherapeutics (CLDI) pay a dividend?

There are no upcoming dividends for Calidi Biotherapeutics.

When is Calidi Biotherapeutics (AMEX:CLDI) reporting earnings?

Calidi Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Calidi Biotherapeutics (CLDI) going to split?

There is no upcoming split for Calidi Biotherapeutics.

What sector and industry does Calidi Biotherapeutics (CLDI) operate in?

Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.